3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
3
Desmoid Tumors
3
Melanoma
2
Lung Neoplasms
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Solid Tumor, Adult
1
Skin Neoplasms
1
Sarcoma
1
Pancreatic Adenocarcinoma Locally Advanced
1
Neuroma
1
Neuralgia
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Liver Metastasis
1
Hypesthesia
1
Disease
1
Colorectal Neoplasms
1
Cirrhosis, Familial, with Pulmonary Hypertension
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Agnosia
1
Adenocarcinoma of Lung
1
Interventions
pembrolizumab
2
toripalimab
1
tislelizumab
1
spartalizumab
1
peposertib
1
pazopanib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
lenvatinib
1
atezolizumab
1
amivantamab
1
Tiragolumab
1
Cryosurgery
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Solid Tumor, Adult
×
Cryosurgery
×
Clear all
NCT06032845
2025-02-27
CASTLE-11
Fudan University
Phase 2
Recruiting
25 enrolled